Suppr超能文献

长期透析患者的 SF-36 和 SF-12 综合评分比较及随后的住院和死亡风险。

A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients.

机构信息

Clinical Sciences, Epidemiology, and Research, Fresenius Medical Care, North America, Waltham, Massachusetts 02451-1457, USA.

出版信息

Clin J Am Soc Nephrol. 2010 Feb;5(2):252-60. doi: 10.2215/CJN.07231009. Epub 2009 Dec 17.

Abstract

BACKGROUND AND OBJECTIVES

The Short Form 12 (SF-12) has not been validated for long-term dialysis patients. The study compared physical and mental component summary (PCS/MCS) scores from the SF-36 with those from the embedded SF-12 in a national cohort of dialysis patients.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All 44,395 patients who had scorable SF-36 and SF-12 from January 1, 2006, to December 31, 2006, and were treated at Fresenius Medical Care, North America facilities were included. Death and first hospitalization were followed for up to 1 year from the date of survey. Correlation and agreement were obtained between PCS-36 and PCS-12 and MCS-36 and MCS-12; then Cox models were constructed to compare associated hazard ratios (HRs) between them.

RESULTS

Physical and mental dimensions both exhibited excellent intraclass correlation coefficients of 0.94. Each incremental point for both PCS-12 and PCS-36 was associated with a 2.4% lower adjusted HR of death and 0.4% decline in HR for first hospitalization (both P < 0.0001). Corresponding improvement in HR of death for each MCS point was 1.2% for MCS-12 and 1.3% for MCS-36, whereas both had similar 0.6% lower HR for hospitalization per point (all P < 0.0001).

CONCLUSIONS

The use of the SF-12 alone or as part of a larger survey is valid in dialysis patients. Composite scores from the SF-12 and SF-36 have similar prognostic association with death and hospitalization risk. Prospective longitudinal studies of SF-12 surveys that consider responsiveness to specific clinical, situational, and interventional changes are needed in this population.

摘要

背景与目的

SF-12 量表尚未在长期透析患者中得到验证。本研究比较了全国性透析患者队列中 SF-36 的生理和心理成分综合评分(PCS/MCS)与嵌入 SF-12 的 PCS/MCS 评分。

设计、设置、参与者和测量:纳入 2006 年 1 月 1 日至 12 月 31 日期间在 Fresenius Medical Care,North America 接受治疗且 SF-36 和 SF-12 评分可评估的所有 44395 例患者。从调查日期起,对死亡和首次住院进行了长达 1 年的随访。获得了 PCS-36 和 PCS-12 以及 MCS-36 和 MCS-12 之间的相关性和一致性;然后构建了 Cox 模型以比较它们之间相关的危险比(HR)。

结果

生理和心理维度均表现出优异的组内相关系数 0.94。PCS-12 和 PCS-36 的每增加 1 分,死亡的调整后 HR 降低 2.4%,首次住院的 HR 降低 0.4%(均 P<0.0001)。对于 MCS 点,每增加一个点,死亡的 HR 相应改善 1.2%(MCS-12)和 1.3%(MCS-36),而每增加一个点,住院的 HR 均降低 0.6%(均 P<0.0001)。

结论

SF-12 单独使用或作为更大规模调查的一部分在透析患者中是有效的。SF-12 和 SF-36 的综合评分与死亡和住院风险具有相似的预后相关性。在该人群中需要进行前瞻性纵向研究,以评估 SF-12 调查对特定临床、情境和干预变化的反应能力。

相似文献

1
A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients.
Clin J Am Soc Nephrol. 2010 Feb;5(2):252-60. doi: 10.2215/CJN.07231009. Epub 2009 Dec 17.
2
Short-Form 12 or Short-Form 36 to measure quality-of-life changes in dialysis patients?
Nephrol Dial Transplant. 2015 Jul;30(7):1170-6. doi: 10.1093/ndt/gfv066. Epub 2015 Mar 31.
5
The association between mental health, physical function, and hemodialysis mortality.
Kidney Int. 2003 May;63(5):1843-51. doi: 10.1046/j.1523-1755.2003.00931.x.
6
Depressive affect and hospitalization risk in incident hemodialysis patients.
Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1713-9. doi: 10.2215/CJN.01340214. Epub 2014 Oct 2.
7
Self-assessed physical and mental function of haemodialysis patients.
Nephrol Dial Transplant. 2001 Jul;16(7):1387-94. doi: 10.1093/ndt/16.7.1387.
8
Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.
Nephrol Dial Transplant. 2017 Mar 1;32(3):521-527. doi: 10.1093/ndt/gfw233.
10
Association between achievement of hemodialysis quality-of-care indicators and quality-of-life scores.
Am J Kidney Dis. 2009 Dec;54(6):1098-107. doi: 10.1053/j.ajkd.2009.07.017. Epub 2009 Sep 25.

引用本文的文献

1
The Minimal Clinically Important Difference for the "Patient Activation Measure".
Kidney Int Rep. 2025 May 14;10(7):2275-2283. doi: 10.1016/j.ekir.2025.04.044. eCollection 2025 Jul.
3
Pain Scales: What Are They and What Do They Mean.
Curr Pain Headache Rep. 2024 Jan;28(1):11-25. doi: 10.1007/s11916-023-01195-2. Epub 2023 Dec 7.
4
Effects of WeChat platform-based continuing care on self-management and quality of life in patients with arthritis: A quasi-experimental study.
Digit Health. 2023 Sep 18;9:20552076231197104. doi: 10.1177/20552076231197104. eCollection 2023 Jan-Dec.
5
Health-Related Quality of Life Scores and Values as Predictors of Mortality: A Scoping Review.
J Gen Intern Med. 2023 Nov;38(15):3389-3405. doi: 10.1007/s11606-023-08380-4. Epub 2023 Aug 31.
6
Dialysis withdrawal and symptoms of anxiety and depression: a prospective cohort study.
BMC Nephrol. 2023 Jul 24;24(1):219. doi: 10.1186/s12882-023-03267-2.
8
A blended e-health intervention for improving functional capacity in elderly patients on haemodialysis: A feasibility study.
Front Digit Health. 2022 Dec 6;4:1054932. doi: 10.3389/fdgth.2022.1054932. eCollection 2022.

本文引用的文献

1
Biomarkers and health-related quality of life in end-stage renal disease: a systematic review.
Clin J Am Soc Nephrol. 2008 Nov;3(6):1759-68. doi: 10.2215/CJN.00820208. Epub 2008 Oct 1.
2
Factors associated with health-related quality of life among hemodialysis patients in the DOPPS.
Qual Life Res. 2007 May;16(4):545-57. doi: 10.1007/s11136-006-9143-7. Epub 2007 Feb 8.
3
Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis.
Qual Life Res. 2007 Jun;16(5):755-65. doi: 10.1007/s11136-007-9176-6. Epub 2007 Feb 8.
5
Health-related quality of life and estimates of utility in chronic kidney disease.
Kidney Int. 2005 Dec;68(6):2801-8. doi: 10.1111/j.1523-1755.2005.00752.x.
6
Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Am J Kidney Dis. 2004 Nov;44(5 Suppl 2):54-60. doi: 10.1053/j.ajkd.2004.08.012.
7
9
Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures.
J Am Soc Nephrol. 2004 Mar;15(3):743-53. doi: 10.1097/01.asn.0000113315.81448.ca.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验